Award
NIH Reporter #5P50CA165962-13
Targeted Therapies for Glioma
Recipient
Brigham and Women's Hospital
Award Amount
$2,441,596.00
Ceiling
$2,441,596.00
Awarded
August 27, 2026
Identifier
5P50CA165962-13
NIH grant awarded to Brigham and Women's Hospital for research on targeted therapies for gliomas, focusing on pediatric and aggressive gliomas using innovative therapeutic approaches and clinical trials.
Description
This project focuses on developing non-toxic, curative treatments for gliomas in children and young adults. The research involves three main projects targeting Pediatric Low-Grade Gliomas, Diffuse Midline Gliomas, and IDH Mutant Gliomas using various therapeutic strategies and clinical trials. The program is supported by cores for Pathology and Biostatistics, and an administrative core to facilitate collaborations among Harvard Medical School and associated hospitals.